Antibody response to human immunodeficiency virus after primary infection

D A Cooper, A. Imrie, R Penny

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

The antibody response to human immunodeficiency virus (HIV) after primary infection was monitored in eight homosexual men with the acute mononucleosis-like illness associated with seroconversion. Multiple sera from each subject, taken at frequent intervals after onset of acute illness, were tested for antibody to HIV by IgM and IgG immunofluorescent assays (IFAs), four commercial enzyme-linked immunosorbent assays (ELISAs), and Western immunoblot (WB). Antibody to HIV was detected first by IgM IFA (mean +/- SD, 5 +/- 3 days), followed by IgG IFA (11 +/- 3 days); the IgM antibody titer peaked at 24 +/- 17 days and disappeared by 81 +/- 27 days, whereas the IgG antibody titer peaked at 133 +/- 63 days and has not disappeared in any subject. Antibody to HIV was first detected by ELISA from 31 +/- 14 to 58 +/- 32 days, depending on the assay kit used. Antibody to p24 and gp41 was first detected by WB at 24 +/- 10 days, followed by antibody to p55 (40 +/- 20 days), p68 (57 +/- 19 days), and p34 (71 +/- 22 days).

Original languageEnglish
Pages (from-to)1113-8
Number of pages6
JournalThe Journal of infectious diseases
Volume155
Issue number6
Publication statusPublished - Jun 1987

Fingerprint

Antibody Formation
HIV
Antibodies
Infection
Immunoglobulin M
Immunoglobulin G
Enzyme-Linked Immunosorbent Assay
Western Blotting
Serum

Cite this

@article{24052c82d4ae408a9f9b38e0ab304b5f,
title = "Antibody response to human immunodeficiency virus after primary infection",
abstract = "The antibody response to human immunodeficiency virus (HIV) after primary infection was monitored in eight homosexual men with the acute mononucleosis-like illness associated with seroconversion. Multiple sera from each subject, taken at frequent intervals after onset of acute illness, were tested for antibody to HIV by IgM and IgG immunofluorescent assays (IFAs), four commercial enzyme-linked immunosorbent assays (ELISAs), and Western immunoblot (WB). Antibody to HIV was detected first by IgM IFA (mean +/- SD, 5 +/- 3 days), followed by IgG IFA (11 +/- 3 days); the IgM antibody titer peaked at 24 +/- 17 days and disappeared by 81 +/- 27 days, whereas the IgG antibody titer peaked at 133 +/- 63 days and has not disappeared in any subject. Antibody to HIV was first detected by ELISA from 31 +/- 14 to 58 +/- 32 days, depending on the assay kit used. Antibody to p24 and gp41 was first detected by WB at 24 +/- 10 days, followed by antibody to p55 (40 +/- 20 days), p68 (57 +/- 19 days), and p34 (71 +/- 22 days).",
keywords = "Acquired Immunodeficiency Syndrome/immunology, Antibodies, Viral/analysis, Enzyme-Linked Immunosorbent Assay, Fluorescent Antibody Technique, HIV/immunology, HIV Antibodies, Homosexuality, Humans, Immunoglobulin G/analysis, Immunoglobulin M/analysis, Immunologic Techniques, Male",
author = "Cooper, {D A} and A. Imrie and R Penny",
year = "1987",
month = "6",
language = "English",
volume = "155",
pages = "1113--8",
journal = "Journal Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "6",

}

Antibody response to human immunodeficiency virus after primary infection. / Cooper, D A; Imrie, A.; Penny, R.

In: The Journal of infectious diseases, Vol. 155, No. 6, 06.1987, p. 1113-8.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Antibody response to human immunodeficiency virus after primary infection

AU - Cooper, D A

AU - Imrie, A.

AU - Penny, R

PY - 1987/6

Y1 - 1987/6

N2 - The antibody response to human immunodeficiency virus (HIV) after primary infection was monitored in eight homosexual men with the acute mononucleosis-like illness associated with seroconversion. Multiple sera from each subject, taken at frequent intervals after onset of acute illness, were tested for antibody to HIV by IgM and IgG immunofluorescent assays (IFAs), four commercial enzyme-linked immunosorbent assays (ELISAs), and Western immunoblot (WB). Antibody to HIV was detected first by IgM IFA (mean +/- SD, 5 +/- 3 days), followed by IgG IFA (11 +/- 3 days); the IgM antibody titer peaked at 24 +/- 17 days and disappeared by 81 +/- 27 days, whereas the IgG antibody titer peaked at 133 +/- 63 days and has not disappeared in any subject. Antibody to HIV was first detected by ELISA from 31 +/- 14 to 58 +/- 32 days, depending on the assay kit used. Antibody to p24 and gp41 was first detected by WB at 24 +/- 10 days, followed by antibody to p55 (40 +/- 20 days), p68 (57 +/- 19 days), and p34 (71 +/- 22 days).

AB - The antibody response to human immunodeficiency virus (HIV) after primary infection was monitored in eight homosexual men with the acute mononucleosis-like illness associated with seroconversion. Multiple sera from each subject, taken at frequent intervals after onset of acute illness, were tested for antibody to HIV by IgM and IgG immunofluorescent assays (IFAs), four commercial enzyme-linked immunosorbent assays (ELISAs), and Western immunoblot (WB). Antibody to HIV was detected first by IgM IFA (mean +/- SD, 5 +/- 3 days), followed by IgG IFA (11 +/- 3 days); the IgM antibody titer peaked at 24 +/- 17 days and disappeared by 81 +/- 27 days, whereas the IgG antibody titer peaked at 133 +/- 63 days and has not disappeared in any subject. Antibody to HIV was first detected by ELISA from 31 +/- 14 to 58 +/- 32 days, depending on the assay kit used. Antibody to p24 and gp41 was first detected by WB at 24 +/- 10 days, followed by antibody to p55 (40 +/- 20 days), p68 (57 +/- 19 days), and p34 (71 +/- 22 days).

KW - Acquired Immunodeficiency Syndrome/immunology

KW - Antibodies, Viral/analysis

KW - Enzyme-Linked Immunosorbent Assay

KW - Fluorescent Antibody Technique

KW - HIV/immunology

KW - HIV Antibodies

KW - Homosexuality

KW - Humans

KW - Immunoglobulin G/analysis

KW - Immunoglobulin M/analysis

KW - Immunologic Techniques

KW - Male

M3 - Article

VL - 155

SP - 1113

EP - 1118

JO - Journal Infectious Diseases

JF - Journal Infectious Diseases

SN - 0022-1899

IS - 6

ER -